Clinic for Internal Medicine II, Haematology and Internal Oncology, University Hospital Jena, Jena, Germany;
Bundesverband der Kehlkopfoperierten e.V., Bonn, Germany.
Anticancer Res. 2023 Apr;43(4):1663-1673. doi: 10.21873/anticanres.16318.
BACKGROUND/AIM: Head and neck cancer (HNC) is associated with a high risk of malnutrition. Malnutrition is defined as acute weight loss greater than 5% and increases mortality 1.7-fold for HNC patients. The aim of the study was to investigate the social and nutritional impairments that patients face throughout cancer-survivorship.
The study was conducted nationwide via the self-help network and in a single oncological center. We analysed 134 patient reported outcome (PRO) questionnaires with a mean age of 65.5±9.4 years, including 88 males, 36 females, and ten participants of undisclosed sex. The questionnaire contained 47 items enquiring about demography, weight development, and how treatment impaired nutrition.
The patient data showed a weight loss of 8% after surgery, 13% after (chemo)radiotherapy [(C)RT] and a return to baseline weight in convalescence. However, patients with a baseline weight >100 kilogram (kg), had a 22% weight loss after (C)RT (p<0.0001) and this remained permanent at 11% (p=0.0041). Treatment-associated side-effects gradually decreased in the course compared to the time of treatment: loss of taste (55% to 21%), xerostomia (56% to 42%), dysphagia (57% to 43%), and dental problems (33%/ to 21%). (C)RT immediately led to more loss of taste (p=0.0461) and dysphagia (p=0.0334), and surgery as a singular modality scored the lowest odds ratio for side-effects. Social Impact: mood, supporting networks, and supplement satisfaction were rated "good" (Likert Scale).
Malnutrition is common among HNC patients. High baseline weight and extensive multimodal treatment are important risk factors that require enhanced stewardship.
背景/目的:头颈部癌症(HNC)与营养不良的风险较高相关。营养不良定义为急性体重减轻超过 5%,并使 HNC 患者的死亡率增加 1.7 倍。本研究旨在探讨癌症患者在生存过程中面临的社会和营养障碍。
本研究在全国范围内通过自助网络和单一肿瘤中心进行。我们分析了 134 份患者报告的结果(PRO)问卷,平均年龄为 65.5±9.4 岁,包括 88 名男性、36 名女性和 10 名未公开性别的参与者。问卷包含 47 个项目,询问人口统计学、体重变化以及治疗如何影响营养。
患者数据显示手术后体重减轻 8%,(放)化疗后体重减轻 13%,在康复期体重恢复到基线水平。然而,基线体重>100 公斤(kg)的患者在(放)化疗后体重减轻 22%(p<0.0001),这一比例在 11%(p=0.0041)时保持不变。与治疗时相比,治疗相关的副作用在治疗过程中逐渐减少:味觉丧失(55%至 21%)、口干(56%至 42%)、吞咽困难(57%至 43%)和牙齿问题(33%/至 21%)。(放)化疗立即导致味觉丧失(p=0.0461)和吞咽困难(p=0.0334)更多,而单一手术模式的副作用发生几率最低。社会影响:情绪、支持网络和补充剂满意度被评为“良好”(Likert 量表)。
HNC 患者中营养不良很常见。高基线体重和广泛的多模式治疗是需要加强管理的重要危险因素。